In High cholesterol Rosycap D3 10 mg/1000 IU Tablet effectively reduces the high cholesterol levels in your body and prevents the absorption of excess of cholesterol from the food that you eat. Lowering the amount of cholesterol reduces the chances of heart diseases and helps you remain healthier for longer. It also contains Vitamin D3 supplements, that help relieve any muscle pain that may be caused due to the cholesterol lowering medicine. Additionally, they also improve heart health. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.
It is unsafe to consume alcohol with Rosycap D3 10 mg/1000 IU Tablet.
Rosycap D3 10 mg/1000 IU Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Rosycap D3 10 mg/1000 IU Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Rosycap D3 10 mg/1000 IU Tablet does not usually affect your ability to drive.
Rosycap D3 10 mg/1000 IU Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rosycap D3 10 mg/1000 IU Tablet may not be needed in these patients. Please consult your doctor.
Rosycap D3 10 mg/1000 IU Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Rosycap D3 10 mg/1000 IU Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Rosycap D3 10 mg/1000 IU Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Goddres Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Converge Biotech || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lloyd Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Europa Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)